Ashley Haralson Vernon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastric Bypass | 11 | 2024 | 824 | 0.930 |
Why?
|
Gastroplasty | 7 | 2021 | 159 | 0.750 |
Why?
|
Obesity, Morbid | 11 | 2022 | 1300 | 0.670 |
Why?
|
Bariatric Surgery | 7 | 2024 | 1001 | 0.600 |
Why?
|
Laparoscopy | 11 | 2021 | 2055 | 0.550 |
Why?
|
Obesity | 11 | 2024 | 13091 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 12 | 2024 | 12253 | 0.310 |
Why?
|
Weight Loss | 10 | 2024 | 2721 | 0.300 |
Why?
|
Appendectomy | 3 | 2012 | 443 | 0.300 |
Why?
|
Adipose Tissue, White | 2 | 2024 | 371 | 0.250 |
Why?
|
Receptors, Gastrointestinal Hormone | 1 | 2024 | 45 | 0.240 |
Why?
|
Gastrectomy | 5 | 2022 | 693 | 0.220 |
Why?
|
Hernia, Hiatal | 2 | 2016 | 91 | 0.210 |
Why?
|
Cholic Acid | 1 | 2020 | 31 | 0.180 |
Why?
|
Appendicitis | 2 | 2006 | 689 | 0.180 |
Why?
|
Insufflation | 1 | 2020 | 64 | 0.170 |
Why?
|
Comprehensive Health Care | 1 | 2020 | 123 | 0.170 |
Why?
|
Digestive System Surgical Procedures | 2 | 2004 | 584 | 0.170 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 2020 | 101 | 0.160 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 93 | 0.150 |
Why?
|
Short Bowel Syndrome | 1 | 2001 | 353 | 0.140 |
Why?
|
Hypoglycemic Agents | 4 | 2019 | 3110 | 0.140 |
Why?
|
Gastroesophageal Reflux | 4 | 2016 | 836 | 0.140 |
Why?
|
Anti-Obesity Agents | 1 | 2020 | 240 | 0.140 |
Why?
|
Liver | 2 | 2021 | 7578 | 0.120 |
Why?
|
Community Health Services | 1 | 2020 | 659 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 559 | 0.120 |
Why?
|
Vagotomy, Proximal Gastric | 1 | 2014 | 8 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 1009 | 0.120 |
Why?
|
Hospitals, Pediatric | 1 | 2003 | 1876 | 0.110 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.110 |
Why?
|
Energy Metabolism | 1 | 2024 | 2905 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1248 | 0.100 |
Why?
|
Intestines | 1 | 2001 | 1911 | 0.100 |
Why?
|
Bone Remodeling | 1 | 2015 | 583 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1891 | 0.090 |
Why?
|
Calcium | 1 | 2024 | 5792 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1119 | 0.090 |
Why?
|
Intussusception | 1 | 2012 | 116 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2016 | 1070 | 0.090 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2211 | 0.080 |
Why?
|
Cost Savings | 1 | 2014 | 915 | 0.080 |
Why?
|
Fetal Mortality | 1 | 2007 | 19 | 0.070 |
Why?
|
Task Performance and Analysis | 1 | 2012 | 771 | 0.070 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2021 | 374 | 0.070 |
Why?
|
Reoperation | 5 | 2021 | 4342 | 0.070 |
Why?
|
Biliary Tract Diseases | 1 | 2007 | 159 | 0.070 |
Why?
|
Treatment Outcome | 12 | 2024 | 65480 | 0.070 |
Why?
|
Fundoplication | 2 | 2004 | 145 | 0.070 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2007 | 236 | 0.060 |
Why?
|
Body Mass Index | 5 | 2024 | 13055 | 0.060 |
Why?
|
Blood Glucose | 5 | 2021 | 6435 | 0.060 |
Why?
|
Specialties, Surgical | 1 | 2009 | 393 | 0.060 |
Why?
|
Pyloric Stenosis | 1 | 2004 | 28 | 0.060 |
Why?
|
Male | 25 | 2024 | 365203 | 0.060 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2024 | 131 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22379 | 0.060 |
Why?
|
Alabama | 1 | 2003 | 112 | 0.060 |
Why?
|
Pylorus | 1 | 2004 | 86 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2021 | 81903 | 0.050 |
Why?
|
Th1 Cells | 1 | 2008 | 1042 | 0.050 |
Why?
|
Humans | 35 | 2024 | 768970 | 0.050 |
Why?
|
Middle Aged | 17 | 2024 | 223737 | 0.050 |
Why?
|
Adult | 17 | 2024 | 223851 | 0.050 |
Why?
|
Intraoperative Period | 1 | 2003 | 513 | 0.050 |
Why?
|
Gastroscopy | 1 | 2004 | 213 | 0.050 |
Why?
|
Laboratories, Hospital | 1 | 2003 | 192 | 0.050 |
Why?
|
Dipeptidases | 1 | 2021 | 38 | 0.050 |
Why?
|
Esophagoscopy | 1 | 2004 | 398 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 69 | 0.050 |
Why?
|
Adipocytes | 2 | 2024 | 1199 | 0.050 |
Why?
|
Esophagogastric Junction | 1 | 2004 | 351 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10400 | 0.050 |
Why?
|
Life Style | 3 | 2019 | 3931 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2021 | 126 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39394 | 0.040 |
Why?
|
Germ-Free Life | 1 | 2021 | 187 | 0.040 |
Why?
|
Female | 22 | 2024 | 397515 | 0.040 |
Why?
|
Health Care Costs | 1 | 2014 | 3270 | 0.040 |
Why?
|
Sulfotransferases | 1 | 2021 | 150 | 0.040 |
Why?
|
Thermogenesis | 1 | 2024 | 494 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2021 | 378 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2008 | 3163 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2020 | 367 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5954 | 0.040 |
Why?
|
Mice, Obese | 1 | 2020 | 418 | 0.040 |
Why?
|
Bile | 1 | 2020 | 299 | 0.040 |
Why?
|
Sulfates | 1 | 2020 | 379 | 0.040 |
Why?
|
Learning Curve | 1 | 2021 | 232 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2020 | 187 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8760 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2009 | 1674 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2003 | 641 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 361 | 0.040 |
Why?
|
Ileum | 1 | 2021 | 558 | 0.040 |
Why?
|
Esophagus | 1 | 2004 | 1043 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2020 | 325 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1669 | 0.040 |
Why?
|
Carcinoma | 1 | 2009 | 2340 | 0.040 |
Why?
|
Hospital Costs | 1 | 2003 | 959 | 0.040 |
Why?
|
Glucose Tolerance Test | 1 | 2020 | 1183 | 0.040 |
Why?
|
Human Growth Hormone | 1 | 2021 | 651 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2007 | 2974 | 0.030 |
Why?
|
Remission Induction | 1 | 2022 | 2408 | 0.030 |
Why?
|
Quality of Life | 4 | 2020 | 13510 | 0.030 |
Why?
|
Colon | 2 | 2020 | 1803 | 0.030 |
Why?
|
Hydroxycholecalciferols | 1 | 2015 | 44 | 0.030 |
Why?
|
Antacids | 1 | 2016 | 94 | 0.030 |
Why?
|
Equipment Design | 2 | 2015 | 3530 | 0.030 |
Why?
|
Mice | 5 | 2024 | 82072 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20776 | 0.030 |
Why?
|
Drug Costs | 1 | 2003 | 1198 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1610 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1737 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1245 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 22296 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2014 | 123 | 0.030 |
Why?
|
Postprandial Period | 1 | 2015 | 320 | 0.030 |
Why?
|
Animals | 6 | 2024 | 169335 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2007 | 2974 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11932 | 0.030 |
Why?
|
Acute Disease | 1 | 2003 | 7245 | 0.030 |
Why?
|
Anesthesia | 1 | 2003 | 1596 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1134 | 0.020 |
Why?
|
Physical Fitness | 1 | 2016 | 744 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2012 | 15889 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 1991 | 59 | 0.020 |
Why?
|
Insulin Resistance | 2 | 2020 | 3982 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3433 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2014 | 487 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4290 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2448 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4862 | 0.020 |
Why?
|
Jejunum | 1 | 2012 | 475 | 0.020 |
Why?
|
Length of Stay | 1 | 2003 | 6526 | 0.020 |
Why?
|
Young Adult | 4 | 2018 | 60131 | 0.020 |
Why?
|
General Surgery | 2 | 2012 | 1722 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 1803 | 0.020 |
Why?
|
Surgical Stapling | 1 | 2009 | 99 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2021 | 4939 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10868 | 0.020 |
Why?
|
Private Practice | 1 | 2009 | 154 | 0.020 |
Why?
|
Animal Feed | 1 | 2008 | 105 | 0.020 |
Why?
|
Prospective Studies | 4 | 2015 | 54962 | 0.020 |
Why?
|
Receptors, Interferon | 1 | 2008 | 115 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 208 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2012 | 771 | 0.020 |
Why?
|
Aged | 6 | 2020 | 171786 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1447 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2012 | 773 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5544 | 0.020 |
Why?
|
Child | 4 | 2006 | 80960 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2130 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2008 | 796 | 0.020 |
Why?
|
Lipids | 2 | 2014 | 3345 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2012 | 14794 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2009 | 994 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23786 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14484 | 0.020 |
Why?
|
Esophagectomy | 1 | 2009 | 482 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3860 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1755 | 0.020 |
Why?
|
Bone and Bones | 1 | 2015 | 2590 | 0.020 |
Why?
|
Pregnancy Trimester, Third | 1 | 2007 | 586 | 0.010 |
Why?
|
Health Behavior | 1 | 2016 | 2649 | 0.010 |
Why?
|
Infant | 2 | 2004 | 36556 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 2007 | 736 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2008 | 1609 | 0.010 |
Why?
|
Suture Techniques | 1 | 2009 | 779 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2649 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1793 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 979 | 0.010 |
Why?
|
Food Hypersensitivity | 1 | 2011 | 734 | 0.010 |
Why?
|
Workload | 1 | 2009 | 852 | 0.010 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2004 | 128 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5323 | 0.010 |
Why?
|
Intra-Abdominal Fat | 1 | 2008 | 625 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2009 | 1273 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2009 | 729 | 0.010 |
Why?
|
Surgical Wound Dehiscence | 1 | 2004 | 216 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2008 | 1461 | 0.010 |
Why?
|
Hypertrophy | 1 | 2004 | 562 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8513 | 0.010 |
Why?
|
Fetal Development | 1 | 2007 | 777 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2916 | 0.010 |
Why?
|
Child, Preschool | 1 | 2003 | 42683 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3554 | 0.010 |
Why?
|
United States | 3 | 2014 | 73186 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8094 | 0.010 |
Why?
|
Leptin | 1 | 2008 | 1597 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2007 | 1275 | 0.010 |
Why?
|
Reference Values | 1 | 2007 | 4940 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 24333 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2422 | 0.010 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2012 | 1899 | 0.010 |
Why?
|
Cholesterol | 1 | 2008 | 2913 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 1830 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2784 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41808 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10633 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18435 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10592 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2009 | 2909 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 2008 | 0.010 |
Why?
|
Medical Oncology | 1 | 2009 | 2350 | 0.010 |
Why?
|
Stents | 1 | 2009 | 3200 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23653 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2004 | 1176 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2014 | 4879 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1991 | 3447 | 0.010 |
Why?
|
Clinical Competence | 1 | 2012 | 4860 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74976 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 14201 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7603 | 0.010 |
Why?
|
Adolescent | 1 | 2003 | 89244 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3538 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11262 | 0.010 |
Why?
|
Cognition | 1 | 2012 | 7081 | 0.010 |
Why?
|
Palliative Care | 1 | 2009 | 3644 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12095 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21547 | 0.010 |
Why?
|
Macrophages | 1 | 2008 | 5801 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2004 | 3044 | 0.010 |
Why?
|
Hypertension | 1 | 2012 | 8617 | 0.010 |
Why?
|
Internship and Residency | 1 | 2012 | 5956 | 0.010 |
Why?
|
Pregnancy | 1 | 2007 | 30265 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1991 | 6512 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1991 | 6320 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1991 | 12467 | 0.000 |
Why?
|